JPH03215270A - Blood treatment apparatus - Google Patents
Blood treatment apparatusInfo
- Publication number
- JPH03215270A JPH03215270A JP2011258A JP1125890A JPH03215270A JP H03215270 A JPH03215270 A JP H03215270A JP 2011258 A JP2011258 A JP 2011258A JP 1125890 A JP1125890 A JP 1125890A JP H03215270 A JPH03215270 A JP H03215270A
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- blood
- pump
- flow path
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 47
- 210000004369 blood Anatomy 0.000 title claims abstract description 47
- 239000012530 fluid Substances 0.000 claims abstract description 73
- 230000004087 circulation Effects 0.000 claims abstract description 5
- 238000002637 fluid replacement therapy Methods 0.000 claims description 18
- 230000002441 reversible effect Effects 0.000 claims description 10
- 230000017531 blood circulation Effects 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims 4
- 239000002699 waste material Substances 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000000385 dialysis solution Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 230000000322 hemodialysis Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
- A61M1/3451—Substitution rate control as a function of the ultrafiltration rate the difference in weight between both ultra-filtrate and substitution reservoir being used as control signal
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は大量の補液を行う血液処理装置、特に血液枦過
透析法(HDF)や連続血液炉過法(CHF)などが適
用可能な血液処理装置に関するものである。Detailed Description of the Invention (Industrial Field of Application) The present invention relates to a blood processing device that performs large-volume fluid replacement, and particularly to a blood processing device that can perform blood flow dialysis (HDF), continuous blood furnace filtration (CHF), etc. It relates to a processing device.
(従来の技術)
従来より腎不全、肝不全等の患者の血液中に存在する有
毒物質を除去するために血液透析法が適用されているが
、患者によっては血液透析法では充分に治療できない場
合がある。近年このような患者に対し透析と炉過を併用
し、分離された炉液(透析排液の一部)を捨て人工体液
などの補液を血液と混合する血液が過透析法や、血液よ
り有毒物質含有体液、例えば中分子量物質を含む大量の
水分、あるいは老廃物を含む血漿などを連続的に炉過分
離し、分離したが液を捨て、新鮮かつ健全な血漿成分あ
るいは人工的に作られた人工体液などの補液を再度血液
に混合する連続血液枦過法が行われている。(Prior art) Hemodialysis has traditionally been applied to remove toxic substances present in the blood of patients suffering from kidney failure, liver failure, etc. However, some patients may not be treated adequately with hemodialysis. There is. In recent years, dialysis and furnace filtration have been combined for such patients, and the separated furnace fluid (a part of the dialysis waste fluid) is discarded and replacement fluids such as artificial body fluids are mixed with the blood. Substance-containing body fluids, such as large amounts of water containing medium-molecular-weight substances, or plasma containing waste products, are continuously separated in a furnace, and the separated liquid is discarded to produce fresh, healthy plasma components or artificially produced plasma components. A continuous blood perfusion method is used in which a replacement fluid such as an artificial body fluid is mixed with blood again.
かかる処理法においては、低血圧ショック等の副作用を
防止するため廃棄されるが液(または透析液の一部)と
、血液と混合される補液とのバランスをとることが是非
とも必要である。このため通常排液ポンプと補液ポンブ
の2台ポンプを用いて両者の流量を同一に設定する方法
、あるいはダブルチュービングポンプにより、排液流量
と補液流量を同じ値にする方法が採用されている。In such treatment methods, it is absolutely necessary to maintain a balance between the fluid (or part of the dialysate) that is discarded and the replacement fluid that is mixed with the blood in order to prevent side effects such as hypotensive shock. For this reason, a method is usually adopted in which two pumps, a drainage pump and a replacement fluid pump, are used to set the flow rates of both pumps to be the same, or a method is adopted in which a double tubing pump is used to set the drainage fluid flow rate and the replacement fluid flow rate to the same value.
(発明が解決しようとする課題)
しかし補液量(排液量)が多く、特に最近の治療例にみ
られるように2012にまで達すると、血液処理が長時
間に及び従来の2台のポンプあるいはダブルチュービン
グポンプを用いた方法ではポンプ前後の圧力変動に上り
流l変化が生じ補液量と排液量のバランスを保つことが
極めて困難となる。(Problem to be solved by the invention) However, when the amount of fluid replacement (drained fluid amount) is large, especially when it reaches 2012 as seen in recent treatment cases, blood processing takes a long time and the conventional two pumps or In the method using a double tubing pump, pressure fluctuations before and after the pump cause upstream flow l changes, making it extremely difficult to maintain a balance between the amount of replacement fluid and the amount of drained fluid.
したがって本発明の目的は長時間の血液処理においても
補液量と排液量のバランスを確実に保つことのできる血
液処理装置を提供することである。Therefore, an object of the present invention is to provide a blood processing apparatus that can reliably maintain the balance between the amount of fluid replacement and the amount of drained fluid even during long-term blood processing.
(課題を解決するための手段)
本発明は血液体外循環流路に設けられた血液透析器また
は血液が過器と、該血液透析器に設けられた透析液導出
流路または該血液が過器に設けられたが液導出流路と、
該透析液導出流路またはが液導出流路に排液ボンブを介
して接続され、該流路から透析液ま1こはが液の一部を
排液容器内に排出する排液流路と、該血液体外循環流路
に補液ボンプを介して接続され、該流路へ補液容器内の
補液を注入する補液流路と、該補液ボンブまたは排液ポ
ンプをバイパスする流路と、該バイパス流路に設けられ
た正逆回転可能な補正ポンプと、該が液容器と補液容器
の総重量を測定する重量測定手段と、該重量測定手段で
測定された2つの容器の総重量の測定値と血液処理開始
時に測定された初期測定値とを比較しながら両者の偏差
値が零となるまで補正ポンプを正逆転回転させる回転制
御回路とを具備した血液処理装置である。(Means for Solving the Problems) The present invention provides a hemodialyzer or a blood filter provided in an extracorporeal blood circulation flow path, and a dialysate outlet flow path or a blood filter provided in the hemodialyzer. A liquid outlet channel provided in the
The dialysate lead-out flow path is connected to the fluid lead-out flow path via a drainage bomb, and a drainage flow path that discharges a portion of the dialysate or dialysis fluid from the flow path into a drainage container; , a fluid replacement flow path that is connected to the extracorporeal blood circulation flow path via a fluid replacement pump and injects the replacement fluid in the fluid replacement container into the flow path; a flow path that bypasses the fluid replacement bomb or the drainage pump; and the bypass flow. a correction pump that is provided in a path and can be rotated in forward and reverse directions; a weight measuring means for measuring the total weight of the liquid container and the replacement liquid container; and a measured value of the total weight of the two containers measured by the weight measuring means; This blood processing apparatus is equipped with a rotation control circuit that rotates the correction pump in the forward and reverse directions while comparing the initial measured value measured at the start of blood processing until the deviation value between the two becomes zero.
(実施例)
次に本発明の血液処理装置の一実施例を図面にて説明す
る。第1図は血液が過透析法に適用される装置の例であ
り、血液体外循環流路1に設けられた血液透析器2の透
析液人口と出口に接続された透析液導入流路3と透析液
導出流路4と、透析液導出流路4に接続されて透析液の
一部を、排液ボンプ5により排液容器6へ排出する排液
流路7と、血液体外循環流路1に接続され、補液容器8
内の補液を補液ポンプ9により血液体外循環流路1に注
入する補液流路10と、補液ボンブ9をバイパスする流
路11に設けられた正逆転可能な補正ポンプ12と、排
液容器6と補液容器8の総重量を測定する重量測定手段
13および捕正ボンブを正逆転させて排液量と補液量を
バランスさせる回転制御回路14で構成されている。(Example) Next, an example of the blood processing apparatus of the present invention will be described with reference to the drawings. FIG. 1 is an example of a device in which blood is applied to hyperdialysis method, in which a dialysate inlet of a hemodialyzer 2 provided in an extracorporeal blood circulation flow path 1 and a dialysate introduction flow path 3 connected to an outlet are shown in FIG. a dialysate outlet channel 4; a drain channel 7 connected to the dialysate outlet channel 4 to discharge a portion of the dialysate into a drain container 6 by a drain pump 5; and a blood extracorporeal circulation channel 1. is connected to the replenishing fluid container 8.
A fluid replacement channel 10 for injecting the fluid contained in the tank into the extracorporeal blood circulation channel 1 by a fluid replacement pump 9, a correction pump 12 which is provided in a channel 11 that bypasses the fluid replacement bomb 9 and is reversible in the forward and reverse directions, and a drainage container 6. It is comprised of a weight measuring means 13 that measures the total weight of the replacement fluid container 8, and a rotation control circuit 14 that rotates the collection bomb forward and backward to balance the amount of drained fluid and the amount of replacement fluid.
血液体外循環流路1は血液を患者から取り出し、浄化し
た血液を患者へ返す流路て、血液の取り出しは血液ボン
プl5で行われる。また該流路の血液ポンプl5と血液
透析器2間に補液流路lOが接続されている。The extracorporeal blood circulation channel 1 is a channel for taking blood from a patient and returning purified blood to the patient.The blood is taken out by a blood pump 15. Further, a fluid replacement flow path 10 is connected between the blood pump 15 and the hemodialyzer 2 in the flow path.
血液透析器2はキュプロアンモニウムセルロース、ポリ
アクリルニトリル、ポリビニルアルコール系などの中空
繊維あるいはノート状膜を筐体内に収容して、筐体内を
膜で血液側と透析液側に分画したものでHF型人工腎臓
あるいはキール型人工腎臓と呼ばれていろものである。The hemodialyzer 2 houses hollow fibers or notebook-like membranes of cuproammonium cellulose, polyacrylonitrile, polyvinyl alcohol, etc. in the housing, and uses the membrane to separate the inside of the housing into a blood side and a dialysate side. It is variously called a type artificial kidney or a Kiel type artificial kidney.
透析液導入流路3は血液透析器の透析液入口と透析液供
給装置(図示せず)を連結する流路であり、この流路に
は流量計、ヒータなとか取着されている。The dialysate introduction flow path 3 is a flow path that connects the dialysate inlet of the hemodialyzer and a dialysate supply device (not shown), and a flow meter, a heater, etc. are attached to this flow path.
透析液導出流路4は血液透析器の透析液出口と連結され
、透析排液を排出する流路である。この流路には透析液
を血液透析器へ導入する陰圧ポンプ16が取着されてい
る。The dialysate outlet flow path 4 is connected to a dialysate outlet of the hemodialyzer and is a flow path for discharging dialysis fluid. A negative pressure pump 16 is attached to this channel for introducing dialysate into the hemodialyzer.
また透析液導出流路4の陰圧ボンブの上流側に排液流路
7が接続されている。Further, a drainage channel 7 is connected to the upstream side of the negative pressure bomb in the dialysate outlet channel 4 .
補液流路10に設けられた補液ボンブ9と、排液流路7
に設けられた排液ポンプ5は各々独立した口−ラボンブ
であっても、ダブルチュービング型のボンブであっても
よい。通常ダブルチュービング型のポンプが用いられる
。A replacement fluid bomb 9 provided in the replacement fluid flow path 10 and a drain fluid flow path 7
The drain pumps 5 provided in the drain pumps 5 may be independent mouth-to-lab bombs or may be double tubing type bombs. A double tubing type pump is usually used.
補液ボンプ9をバイパスする流路1lに設けられた正逆
回転可能な補正ボンプ12は通常補液ボンブの流量の2
0%以下の流量を有しており、後述する回転制御回路1
4からの信号を受けて補液量と排液量のバランスを保つ
ように正逆回転する。The correction pump 12, which is provided in the flow path 1l that bypasses the replacement fluid bomb 9 and is rotatable in forward and reverse directions, normally has a flow rate of 2 times the flow rate of the replacement fluid bomb.
It has a flow rate of 0% or less, and the rotation control circuit 1 described later
It receives the signal from 4 and rotates forward and backward to maintain the balance between the amount of replacement fluid and the amount of drained fluid.
重量測定手段l3は排液容器6と補液容器8の総重量を
測定するもので公知の測定手段、通常ロードセルが用い
られる。The weight measuring means 13 measures the total weight of the drain fluid container 6 and the replacement fluid container 8, and is a known measuring means, usually a load cell.
回転制御回路14は上記重量測定手段l3からの信て、
初期値〈測定値のときに補正ポンプを正回転させる信号
を駆動回路22に発信して補正ポンプを駆動させ、補液
注入量を増加させる。一方初期値〉測定値のときに補正
ポンプを逆回転させる信号を駆動回路22に発信して、
補正ポ′ンプを駆動させて補液注入量を減少させる。補
正ポンプを測定値と初期値の偏差値が零となるまで駆動
させ、両者の偏差値が零とすると補正ポンプを停止させ
る信号を駆動回路22に発信して補正ポンプを停止させ
る。The rotation control circuit 14 receives the information from the weight measuring means 13,
When the initial value <measured value, a signal to rotate the correction pump in the forward direction is sent to the drive circuit 22 to drive the correction pump and increase the amount of replacement fluid injected. On the other hand, when the initial value>measured value, a signal to reversely rotate the correction pump is sent to the drive circuit 22,
Drive the correction pump to reduce the amount of replacement fluid injected. The correction pump is driven until the deviation value between the measured value and the initial value becomes zero, and when the deviation value between both becomes zero, a signal to stop the correction pump is sent to the drive circuit 22 to stop the correction pump.
次に上記構成の動作について説明する。血液ボンプ15
の回転により患者から血液が100〜200+a&/分
の範囲内で取り出されると、血液は血液透析器2、人体
へと循環される。上記血液透析器では透析液供給装置(
図示せず)から透析液導入流路3を経て血液透析器2へ
透析液が供給され、膜を透過した不要物質及び水分を含
む透析排液が透析液導出流路4から排出される。透析排
液の一部が透析液導出流路4に設けられた排液流路7か
ら排液容器6内に排出される。一方血液体外循環流路1
には補液容器8から浦液流路を介して上記排液容器に排
出される排液と等量の補液が注入される。Next, the operation of the above configuration will be explained. blood pump 15
Once the blood is removed from the patient within the range of 100-200+a&/min by the rotation of the dialyzer 2, the blood is circulated to the hemodialyzer 2 and the human body. In the above hemodialyzer, the dialysate supply device (
A dialysate is supplied to the hemodialyzer 2 from a dialysate (not shown) through a dialysate introduction channel 3, and a dialysis fluid containing unnecessary substances and water that has passed through the membrane is discharged from a dialysate outlet channel 4. A portion of the dialysis fluid is discharged into the drainage container 6 from the drainage channel 7 provided in the dialysate outlet channel 4 . On the other hand, blood extracorporeal circulation flow path 1
A replacement fluid is injected from the replacement fluid container 8 in an amount equal to the drainage fluid discharged into the drainage fluid container through the liquid flow path.
上記補液容器8と排液容器6の総重量は常に重量測定手
段l3で測定され、その信号は回転制御回路14に発信
される。回転制御回路14では血液処理開始時の重量測
定値と測定値が比較されて、初期値く測定値のときに補
正ボンブl2が正回転して補液量が増大し、初期値〉測
定値のときに補正ポンプが逆回転して補液量が減少する
。測定値が初期値と等しくなると補正ポンプの回転が停
止する。したかって補液量と排液量を常時バランスさせ
ることができる。The total weight of the replacement fluid container 8 and the drain fluid container 6 is always measured by the weight measuring means 13, and its signal is sent to the rotation control circuit 14. In the rotation control circuit 14, the weight measurement value at the start of blood processing is compared with the measured value, and when the initial value is less than the measured value, the correction bomb 12 is rotated forward to increase the amount of fluid replacement, and when the initial value is greater than the measured value, the correction bomb 12 is rotated forward. The compensation pump rotates in the opposite direction, reducing the amount of replacement fluid. When the measured value becomes equal to the initial value, the correction pump stops rotating. Therefore, the amount of fluid to be replaced and the amount of drained fluid can always be balanced.
ところで、排液量と補液量とは同量になるように設定し
てあるが、現実には排液ポンブ5と補液ボンプ9の軸の
偏心やチューブ径の寸法誤差、さらには上記ポンプ5.
9の吸引および吐出圧の違いなどが存在し、チューブ内
容積の有効容積が変わり、流量誤差が生じるのは避けら
れない。Incidentally, the amount of drained fluid and the amount of replacement fluid are set to be the same, but in reality, there are problems such as eccentricity of the shafts of the drainage pump 5 and replacement fluid pump 9, dimensional errors in the tube diameters, and furthermore, the pump 5.
9, there are differences in suction and discharge pressures, etc., and the effective volume of the tube internal volume changes, which inevitably causes a flow rate error.
上記流量誤差が生じると虫者の循環血液量が変化するた
め患者の循環器系に対する負担が大きくなり、非常に憂
慮すべき状態となる。When the above-mentioned flow rate error occurs, the amount of circulating blood in the patient changes, which increases the burden on the patient's circulatory system, resulting in a very alarming situation.
しかるに、上記構成では、補液容器と排液容器の総重量
を常に血液処理開始時の総重量と等しくなるよう、補正
ポンプを正逆回転させて補液量を調整することにより排
液量と、補液量との誤差を著しく少なくさせることがで
き、したがって上記安全性を一層助長できるものである
。However, in the above configuration, the amount of fluid to be drained and the amount of fluid to be replaced are adjusted by rotating the correction pump in forward and reverse directions so that the total weight of the fluid replacement container and the drainage fluid container is always equal to the total weight at the start of blood treatment. It is possible to significantly reduce the error in the amount, thus further promoting the above-mentioned safety.
なお、上記実施例では、血液透析するものを例に説明し
たものであるが、たとえば第2図に示すように血i&J
過器30を設け、連続的に血液が遇するものにおいても
、上記が液流路31に設けられたが夜ポンブ32の上流
に排液流路7を接続することにより、が液量と補液量の
バランスを保つことができるのであり、同一部所に同一
番号を付してその説明を省略する。In the above embodiment, the explanation was given using a case where hemodialysis is performed, but for example, as shown in FIG.
Even in the case where a filter 30 is provided and blood is continuously supplied, the above is provided in the liquid flow path 31, but by connecting the drain flow path 7 upstream of the pump 32, the amount of liquid and replacement fluid can be increased. It is possible to maintain a balance in quantity, and the same parts will be given the same numbers and their explanation will be omitted.
また上記説明ではバイパス流路を補液ボンブ側に設けた
例で説明したが、排液ポンプ側にバイパス流路を設けて
も構わない。その場合には補正ボンブの正逆転動作が逆
になる。Further, in the above description, an example has been described in which the bypass flow path is provided on the replacement fluid bomb side, but the bypass flow path may be provided on the drainage pump side. In that case, the forward and reverse operations of the correction bomb are reversed.
(発明の効果)
以上のように本発明は、補液容器と排液容器の総重量を
測定し、血液処理開始時の総重量と比較して補正ポンプ
を正逆回転させる簡単な構成により、補液量と排液量を
確実にバランスさせることができ、安全性の確保に寄与
でき、しかも操作性の優れた血液処理装置を提供するこ
とができる。(Effects of the Invention) As described above, the present invention measures the total weight of the fluid replacement container and the drain fluid container, compares it with the total weight at the start of blood processing, and rotates the correction pump in the forward and reverse directions. It is possible to provide a blood processing device that can reliably balance the volume and drainage volume, contribute to ensuring safety, and has excellent operability.
第1図はこの発明に係る血液処理装置の一例を示すブロ
ック図であり、第2図は他の実施例を示すブロック図で
ある。
血液体外循環流路
血液透析器
透析液導出流路
排液ポンプ
排液容器
排液流路
補液容器
補液ポンプ
補液流路
バイパス流路
補正ポンプ
重量測定手段
回転制御回路FIG. 1 is a block diagram showing an example of a blood processing apparatus according to the present invention, and FIG. 2 is a block diagram showing another embodiment. Blood extracorporeal circulation flow path Hemodialyzer Dialysate outlet flow path Drain pump Drain container Drain flow path Fluid replacement container Fluid replacement pump Fluid replacement flow path Bypass flow path Correction pump Weight measuring means Rotation control circuit
Claims (1)
ろ過器と、該血液透析器に設けられた透析液導出流路ま
たは該血液ろ過器に設けられたろ液導出流路と、該透析
液導出流路またはろ液導出流路に排液ポンプを介して接
続され、該流路から透析液またはろ液の一部を排液容器
内に排出する排液流路と、該血液体外循環流路に補液ポ
ンプを介して接続され該流路へ補液容器内の補液を注入
する補液流路と、該補液ポンプまたは排液ポンプをバイ
パスする流路と、該バイパス流路に設けられた正逆回転
可能な補正ポンプと、該ろ液容器と補液容器の総重量を
測定する重量測定手段と、該重量測定手段で測定された
2つの容器の総重量の測定値と血液処理開始時に測定さ
れた初期測定値とを比較しながら両者の偏差値が零とな
るまで補正ポンプを正逆転回転させる回転制御回路とを
具備した血液処理装置。A hemodialyzer or a hemofilter provided in an extracorporeal blood circulation channel, a dialysate outlet channel provided in the hemodialyzer or a filtrate outlet channel provided in the hemofilter, and a dialysate outlet A drainage channel that is connected to the channel or the filtrate outlet channel via a drainage pump and discharges a portion of the dialysate or filtrate from the channel into the drainage container, and the blood extracorporeal circulation channel. A replacement fluid flow path that is connected to the fluid replacement pump via a replacement fluid pump and injects the replacement fluid in the replacement fluid container into the flow path, a flow path that bypasses the replacement fluid pump or the drainage pump, and a forward and reverse rotation provided in the bypass flow path. a possible compensation pump, a weight measuring means for measuring the total weight of the filtrate container and the replacement fluid container, a measured value of the total weight of the two containers measured by the weight measuring means and an initial value measured at the start of the blood treatment. A blood processing device comprising a rotation control circuit that rotates a correction pump in the forward and reverse directions while comparing the measured values with each other until the deviation value between the two becomes zero.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011258A JPH0822312B2 (en) | 1990-01-19 | 1990-01-19 | Blood processing equipment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011258A JPH0822312B2 (en) | 1990-01-19 | 1990-01-19 | Blood processing equipment |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03215270A true JPH03215270A (en) | 1991-09-20 |
JPH0822312B2 JPH0822312B2 (en) | 1996-03-06 |
Family
ID=11772917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011258A Expired - Lifetime JPH0822312B2 (en) | 1990-01-19 | 1990-01-19 | Blood processing equipment |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0822312B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007236924A (en) * | 2006-02-07 | 2007-09-20 | Jms Co Ltd | Blood purification apparatus |
JP2007236923A (en) * | 2006-02-07 | 2007-09-20 | Jms Co Ltd | Blood purification circuit |
JP2014513990A (en) * | 2011-02-01 | 2014-06-19 | フレセニウス メディカル ケア ドイチュランド ゲーエムベーハー | Control method and control apparatus for extracorporeal blood treatment apparatus |
US9011678B2 (en) | 2006-02-07 | 2015-04-21 | Jms Co., Ltd. | Blood purification apparatus and blood purification circuit |
JP2018027205A (en) * | 2016-08-18 | 2018-02-22 | ニプロ株式会社 | Blood purification device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5493899A (en) * | 1978-01-09 | 1979-07-25 | Toray Industries | Outer filter |
JPS595304A (en) * | 1982-07-02 | 1984-01-12 | Yaskawa Electric Mfg Co Ltd | Write confirming method of external memory in sequence control |
JPS6325804A (en) * | 1986-07-17 | 1988-02-03 | Rohm Co Ltd | Magnetic recording and reproducing circuit |
JPS6329655A (en) * | 1986-07-23 | 1988-02-08 | 日機装株式会社 | Artificial kidney apparatus |
-
1990
- 1990-01-19 JP JP2011258A patent/JPH0822312B2/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5493899A (en) * | 1978-01-09 | 1979-07-25 | Toray Industries | Outer filter |
JPS595304A (en) * | 1982-07-02 | 1984-01-12 | Yaskawa Electric Mfg Co Ltd | Write confirming method of external memory in sequence control |
JPS6325804A (en) * | 1986-07-17 | 1988-02-03 | Rohm Co Ltd | Magnetic recording and reproducing circuit |
JPS6329655A (en) * | 1986-07-23 | 1988-02-08 | 日機装株式会社 | Artificial kidney apparatus |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007236924A (en) * | 2006-02-07 | 2007-09-20 | Jms Co Ltd | Blood purification apparatus |
JP2007236923A (en) * | 2006-02-07 | 2007-09-20 | Jms Co Ltd | Blood purification circuit |
US9011678B2 (en) | 2006-02-07 | 2015-04-21 | Jms Co., Ltd. | Blood purification apparatus and blood purification circuit |
JP2014513990A (en) * | 2011-02-01 | 2014-06-19 | フレセニウス メディカル ケア ドイチュランド ゲーエムベーハー | Control method and control apparatus for extracorporeal blood treatment apparatus |
JP2018027205A (en) * | 2016-08-18 | 2018-02-22 | ニプロ株式会社 | Blood purification device |
Also Published As
Publication number | Publication date |
---|---|
JPH0822312B2 (en) | 1996-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190388604A1 (en) | Blood rinseback system and method | |
EP1450879B2 (en) | Method of priming a dialysis machine | |
US6139748A (en) | Method and device for monitoring an infusion pump | |
US6132616A (en) | Method for flushing and filling of an extracorporeal blood circulation system of a dialysis machine | |
EP1343576B1 (en) | Method and apparatus for generating a sterile infusion fluid | |
US5902476A (en) | Artificial kidney for frequent (daily) hemodialysis | |
US6156002A (en) | Method of measuring the efficiency of mass and energy transfer in hemodialysis | |
EP1661591B1 (en) | Apparatus for the purification of blood by means of hemodialysis and/or hemofiltration | |
JP4333840B2 (en) | Devices for internal and external purification | |
JP2000107284A (en) | Dialysis apparatus and washing priming method | |
EP1547629B1 (en) | Peritoneal dialyzer | |
JPH03215270A (en) | Blood treatment apparatus | |
JP2001252352A (en) | Method of returning residual blood in blood circuit | |
JP7412296B2 (en) | blood purification device | |
CN212914049U (en) | Modular continuous kidney substitution machine | |
JP2001259024A (en) | Blood return method for residual blood in blood circuit | |
Kawanishi | Clinical results of daily hemofiltration | |
JPH06245994A (en) | Blood purifying device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090306 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100306 Year of fee payment: 14 |
|
EXPY | Cancellation because of completion of term |